BP Lowering Still Decreases CVD Risk Even in CKD
Viktor Zarev
Data from a new Lancet study suggests that patients with chronic kidney disease (CKD) might get similar cardiovascular protection from blood pressure drugs as the general population, giving physicians some certainty about how to approach BP in these patients. Constructing a massive meta-analysis, researchers examined 285k patients to see how BP lowering (using five antihypertensive […] The post BP Lowering Still Decreases CVD Risk Even in CKD appeared first on Cardiac Wire .